Imprimis Pharmaceuticals Licenses IP
socalTECH
JUNE 17, 2013
San Diego-based Imprimis Pharmaceuticals said this morning that it has licensed a set of intellectual property assets, from Buderer Drug Company. Imprimis said it is in the process of filing for a patent on those new IP assets. Imprimis said it is in the process of filing for a patent on those new IP assets. READ MORE>>.
Let's personalize your content